Here, we found that STAT3 was downregulated in response to treatment with MSC-exosomes, suggesting that these particles targeted STAT3 to suppress BCL2 expression and the subsequent activation of apoptosis in AML cells. Here, BCL2 is linked to acute myeloid leukemia.